Summary
Steven Hamblin is a C-suite technology leader with 12 years’ experience building AI-driven products and scaling software teams across healthtech and commercial ventures. He has held senior technical and operational roles at organizations including Babylon Health, Sensyne Health, Clear AI and Drayson Technologies, and transitioned from CEO to CTO at Dyad, reflecting hands-on product and leadership versatility. Trained as a biologist with a PhD and postdoctoral research background, he uniquely bridges deep scientific understanding with practical ML/AI deployment in regulated healthcare contexts. An active advisor and investor based in London, he combines strategic growth focus with day-to-day engineering delivery and regulatory-aware architecture. Notably, his career blends academic rigor with startup tempo, driving AI adoption from research prototypes into operational clinical and commercial systems.
12 years of coding experience
9 years of employment as a software developer
M.Sc Psychology, M.Sc Psychology at University of Alberta
Ph.D. Biology, Ph.D. Biology at UQAM | Université du Québec à Montréal
S2DS